GlassScriptPhysician profile
Ingrid M Gold
NPI 1801894092
$3,823.34
in general payments reported to CMS, 2019-2025
26 companies · $714 in 2025
The $714 reported for 2025 was more than what 98% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $1,405 · 2023: $829 · 2024: $681 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,224.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $898.94 | 2022 | |
| Astellas Pharma US INC | $524.61 | 2023-2025 | Veozah |
| Abbvie INC. | $413.06 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $260.30 | 2021-2025 | |
| Hologic Sales and Service, LLC | $242.83 | 2022-2024 | Aptima, Acessa Provu System, Novasure |
| Sumitomo Pharma America, INC. | $217.65 | 2023-2025 | Myfembree |
| Organon LLC | $216.71 | 2022-2025 | Nexplanon |
| Myriad Women'S Health, INC. | $178.41 | 2023 | Myrisk |
| Shield Therapeutics INC | $143.16 | 2023-2024 | Accrufer |
| Coopersurgical, INC. | $141.16 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $130.13 | 2022-2024 | |
| Daiichi Sankyo INC. | $53.46 | 2022 | |
| Merck Sharp & Dohme LLC | $48.72 | 2023-2025 | Gardasil 9, Vaxneuvance |
| Biogen, INC. | $43.03 | 2025 | Zurzuvae |
| Ethicon US, LLC | $41.73 | 2022-2023 | Ethicon, Dermabond, Stratafix |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $36.95 | 2023-2024 | Ova1 |
| Medtronic, INC. | $35.61 | 2022-2023 | Micra |
| Gynesonics, INC. | $35.03 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $33.75 | 2024 | |
| Gilead Sciences, INC. | $31.72 | 2022-2025 | |
| Boston Scientific Corporation | $18.57 | 2025 | General - Pain Management |
| Mycovia Pharmaceuticals, INC. | $17.92 | 2023 | Vivjoa |
| Mylan Pharmaceuticals INC. | $16.47 | 2021 | |
| Exeltis, USA INC. | $16.14 | 2025 | Slynd |
| Evofem Biosciences, INC. | $14.86 | 2021 | |
| Myovant Sciences INC. | $12.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Gold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.